Evidence map›Paper›PMID 35370602›Full record

ArticleFrontiers in aging neuroscience2022

Subjective Cognitive Decline Is More Accurate When Metamemory Is Better.

Silvia Chapman, Jillian L Joyce, Megan S Barker, Preeti Sunderaraman, Sandra Rizer, Edward D Huey, Jordan Dworkin, Yian Gu, Stephanie Cosentino

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Subjective cognitive decline: Memory complaints, cognitive awareness, and metacognition.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Review
  6. Investigating the Effects of Discrimination Experiences on Everyday Metamemory Accuracy.The journals of gerontology. Series B, Psychological sciences and social sciences · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Silvia ChapmanCognitive Neuroscience Division, Columbia University Irving Medical Center, New York, NY, United States.
Jillian L JoyceCognitive Neuroscience Division, Columbia University Irving Medical Center, New York, NY, United States.
Megan S BarkerCognitive Neuroscience Division, Columbia University Irving Medical Center, New York, NY, United States.
Preeti SunderaramanCognitive Neuroscience Division, Columbia University Irving Medical Center, New York, NY, United States.
Sandra RizerCognitive Neuroscience Division, Columbia University Irving Medical Center, New York, NY, United States.
Edward D HueyCognitive Neuroscience Division, Columbia University Irving Medical Center, New York, NY, United States.
Jordan DworkinCognitive Neuroscience Division, Columbia University Irving Medical Center, New York, NY, United States.
Yian GuCognitive Neuroscience Division, Columbia University Irving Medical Center, New York, NY, United States.
Stephanie CosentinoCognitive Neuroscience Division, Columbia University Irving Medical Center, New York, NY, United States.

Funding

Research Education CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Andrew Franklin Teich · 2020 to 2026
$30.1M
Neuroanatomical associations with the factor structure underlying neuropsychiatric symptoms in Alzheimer's diseaseR01AG062268 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HUEY, EDWARD D · 2018 to 2022
$2.5M
Using RDoC Negative and Positive Valence Paradigms to Investigate the Mechanisms of Neuropsychiatric Symptoms (NPS) in Alzheimer's Disease and Related DementiasR01MH120794 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HUEY, EDWARD D · 2019 to 2023
$2.1M
Task-specific and person-specific factors related to Subjective Cognitive DeclineR01AG054525 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI COSENTINO, STEPHANIE ANN · 2017 to 2021
$2.0M
NIA NIH HHS P30 AG066462NIA NIH HHS R01 AG054525NIA NIH HHS R01 AG062268NIMH NIH HHS R01 MH120794
6 · The paper itself

Abstract

Objective: Subjective cognitive decline (SCD) has emerged as one of the first manifestations of Alzheimer's disease (AD). However, discrepancies in its relationship with tests of memory and other cognitive abilities have hindered SCD's diagnostic utility. Inter-individual heterogeneity in metamemory, or memory awareness, and the use of clinical measures of cognition lacking sensitivity to early cognitive dysfunction, may contribute to these discrepancies. We aimed to assess if the relationship between SCD and markers of early cognitive dysfunction is moderated by metamemory abilities. Methods: The sample included 79 cognitively healthy older adults (77% female, 68% White, and 32% Black participants) with a mean age of 74.4 ( Results: Subjective cognitive decline was associated with susceptibility to semantic proactive interference such that greater complaints were associated with increased susceptibility to semantic proactive interference ( Discussion: The accuracy of an individual's metamemory, specifically their ability to adjust moment to moment predictions in line with their performance, can influence the extent to which SCD maps onto objective cognition. Such self-referential assessment should be considered when interpreting SCD.

Indexed as

early cognitive dysfunctionmetamemorypreclinical Alzheimer’s diseaseself awarenesssubjective cognitive decline

Identifiers

PMID35370602
PMCPMC8965471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.